Protocol for a randomized controlled trial of endoscopic ultrasound guided celiac plexus neurolysis (EUS-CPN) with vs without bupivacaine
Abstract Background Pancreatic cancer is a devastating disease with less than 5% 5-year survival. Inoperable patients often present with pain. Randomized controlled trial have shown that endoscopic ultrasound-guided celiac plexus neurolysis (EUS-CPN) improves pain control. It is usually performed by...
Main Authors: | Eslam Esmail, Sarto C Paquin, Anand V Sahai |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-09-01
|
Series: | Trials |
Online Access: | https://doi.org/10.1186/s13063-023-07487-7 |
Similar Items
-
Recent topics on endoscopic ultrasonography-guided celiac plexus neurolysis
by: Ichiro Yasuda, et al.
Published: (2020-10-01) -
Endoscopic ultrasound-guided celiac plexus neurolysis for managing abdominal pain related with advanced cancer
by: Ryota Nakano, et al.
Published: (2022-07-01) -
Development of a new reagent for endoscopic ultrasound-guided celiac plexus neurolysis and tumor ablation therapy
by: Kazuo Hara, et al.
Published: (2016-10-01) -
EUS-guided celiac plexus neurolysis for pain in pancreatic cancer patients – a meta-analysis and systematic review
by: Abuzar A. Asif, et al.
Published: (2021-07-01) -
Pain Control with Splanchnic Neurolysis in Pancreatic Cancer Patients Unresponsive to Celiac Plexus Neurolysis
by: Comlek S
Published: (2020-08-01)